110 related articles for article (PubMed ID: 31077280)
1. Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals.
Hoel H; Ueland T; Knudsen A; Kjær A; Michelsen AE; Sagen EL; Halvorsen B; Yndestad A; Nielsen SD; Aukrust P; Lebech AM; Trøseid M
J Infect Dis; 2020 Feb; 221(4):506-509. PubMed ID: 31077280
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study.
Rasmussen LJ; Knudsen A; Katzenstein TL; Gerstoft J; Obel N; Jørgensen NR; Kronborg G; Benfield T; Kjaer A; Eugen-Olsen J; Lebech AM
HIV Med; 2016 May; 17(5):350-7. PubMed ID: 26365671
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
Nouhin J; Pean P; Madec Y; Chevalier MF; Didier C; Borand L; Blanc FX; Scott-Algara D; Laureillard D; Weiss L
J Infect; 2017 May; 74(5):456-465. PubMed ID: 28189712
[TBL] [Abstract][Full Text] [Related]
5. Plasma plasminogen activator inhibitor-1 predicts myocardial infarction in HIV-1-infected individuals.
Knudsen A; Katzenstein TL; Benfield T; Jørgensen NR; Kronborg G; Gerstoft J; Obel N; Kjær A; Lebech AM
AIDS; 2014 May; 28(8):1171-9. PubMed ID: 24566095
[TBL] [Abstract][Full Text] [Related]
6. Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection.
Graham SM; Nance RM; Chen J; Wurfel MM; Hunt PW; Heckbert SR; Budoff MJ; Moore RD; Jacobson JM; Martin JN; Crane HM; López JA; Liles WC
J Acquir Immune Defic Syndr; 2023 Aug; 93(4):282-291. PubMed ID: 37018921
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study.
Knudsen A; Møller HJ; Katzenstein TL; Gerstoft J; Obel N; Kronborg G; Benfield T; Kjaer A; Lebech AM
BMC Infect Dis; 2013 May; 13():230. PubMed ID: 23692821
[TBL] [Abstract][Full Text] [Related]
8. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.
Lang S; Mary-Krause M; Simon A; Partisani M; Gilquin J; Cotte L; Boccara F; Costagliola D;
Clin Infect Dis; 2012 Aug; 55(4):600-7. PubMed ID: 22610928
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.
Patti G; Mega S; Pasceri V; Nusca A; Giorgi G; Zardi EM; D'Ambrosio A; Dobrina A; Di Sciascio G
Clin Cardiol; 2005 Apr; 28(4):193-6. PubMed ID: 15869054
[TBL] [Abstract][Full Text] [Related]
10. Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts.
Herder C; de Las Heras Gala T; Carstensen-Kirberg M; Huth C; Zierer A; Wahl S; Sudduth-Klinger J; Kuulasmaa K; Peretz D; Ligthart S; Bongaerts BWC; Dehghan A; Ikram MA; Jula A; Kee F; Pietilä A; Saarela O; Zeller T; Blankenberg S; Meisinger C; Peters A; Roden M; Salomaa V; Koenig W; Thorand B
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1222-1227. PubMed ID: 28428221
[TBL] [Abstract][Full Text] [Related]
11. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
[TBL] [Abstract][Full Text] [Related]
12. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum interleukin-1β levels and interleukin-1β-to-interleukin-1 receptor antagonist ratio 1 week after embryo transfer are associated with ectopic pregnancy.
Lekovich J; Witkin SS; Doulaveris G; Orfanelli T; Shulman B; Pereira N; Rosenwaks Z; Spandorfer SD
Fertil Steril; 2015 Nov; 104(5):1190-4. PubMed ID: 26279136
[TBL] [Abstract][Full Text] [Related]
14. Elevated Levels of Interleukin-1β and Interleukin-10 Are Associated With Faster Lung Function Decline in People With Well-Treated Human Immunodeficiency Virus.
Thudium RF; Arentoft NS; Hoel H; Afzal S; von Stemann JH; Forman JL; Wilcke JT; Benfield T; Trøseid M; Borges ÁH; Ostrowski SR; Vestbo J; Kunisaki KM; Jensen JS; Nielsen SD
J Infect Dis; 2023 Oct; 228(8):1080-1088. PubMed ID: 37366576
[TBL] [Abstract][Full Text] [Related]
15. [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
Selimova LM; Kalnina LB; Serebrovskaya LV; Ivanova LA; Gulyaeva AN; Nosik DN
Vopr Virusol; 2016; 61(1):39-41. PubMed ID: 27145600
[TBL] [Abstract][Full Text] [Related]
16. Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking.
Rasmussen LD; Helleberg M; May MT; Afzal S; Kronborg G; Larsen CS; Pedersen C; Gerstoft J; Nordestgaard BG; Obel N
Clin Infect Dis; 2015 May; 60(9):1415-23. PubMed ID: 25595744
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].
Yang Y; Qiao J; Li MZ
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):9-13. PubMed ID: 22455686
[TBL] [Abstract][Full Text] [Related]
18. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
19. Anti-Inflammatory Interleukin 10 Inversely Relates to Coronary Atherosclerosis in Persons With Human Immunodeficiency Virus.
Fourman LT; Saylor CF; Cheru L; Fitch K; Looby S; Keller K; Robinson JA; Hoffmann U; Lu MT; Burdo T; Lo J
J Infect Dis; 2020 Feb; 221(4):510-515. PubMed ID: 31077265
[TBL] [Abstract][Full Text] [Related]
20. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.
Olofsson PS; Sheikine Y; Jatta K; Ghaderi M; Samnegård A; Eriksson P; Sirsjö A
Circ J; 2009 Aug; 73(8):1531-6. PubMed ID: 19574724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
